Cargando…

Hepatitis and Cholangiohepatitis

• Although many causes of hepatitis and cholangiohepatitis have been described in dogs and cats, the etiology in many cases remains unknown. • A suspicion of hepatitis or cholangiohepatitis may be based on supportive historical, physical examination, and clinicopathologic findings that are similar f...

Descripción completa

Detalles Bibliográficos
Autor principal: Rondeau, Mark P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152088/
http://dx.doi.org/10.1016/B978-1-4160-2591-7.10126-2
_version_ 1783521399325851648
author Rondeau, Mark P.
author_facet Rondeau, Mark P.
author_sort Rondeau, Mark P.
collection PubMed
description • Although many causes of hepatitis and cholangiohepatitis have been described in dogs and cats, the etiology in many cases remains unknown. • A suspicion of hepatitis or cholangiohepatitis may be based on supportive historical, physical examination, and clinicopathologic findings that are similar for most causes of hepatic disease. A diagnosis of hepatitis or cholangiohepatitis is ultimately made via histopathologic evaluation of hepatic tissue. • The mechanisms of hepatocellular injury in animals with hepatitis and cholangiohepatitis are poorly understood. Elucidation of these mechanisms may provide the basis for future therapeutic options. • Successful treatment of the patient with hepatitis or cholangiohepatitis involves addressing the underlying disease or inciting cause and providing aggressive symptomatic therapy and supportive care.
format Online
Article
Text
id pubmed-7152088
institution National Center for Biotechnology Information
language English
publishDate 2009
record_format MEDLINE/PubMed
spelling pubmed-71520882020-04-13 Hepatitis and Cholangiohepatitis Rondeau, Mark P. Small Animal Critical Care Medicine Article • Although many causes of hepatitis and cholangiohepatitis have been described in dogs and cats, the etiology in many cases remains unknown. • A suspicion of hepatitis or cholangiohepatitis may be based on supportive historical, physical examination, and clinicopathologic findings that are similar for most causes of hepatic disease. A diagnosis of hepatitis or cholangiohepatitis is ultimately made via histopathologic evaluation of hepatic tissue. • The mechanisms of hepatocellular injury in animals with hepatitis and cholangiohepatitis are poorly understood. Elucidation of these mechanisms may provide the basis for future therapeutic options. • Successful treatment of the patient with hepatitis or cholangiohepatitis involves addressing the underlying disease or inciting cause and providing aggressive symptomatic therapy and supportive care. 2009 2009-11-30 /pmc/articles/PMC7152088/ http://dx.doi.org/10.1016/B978-1-4160-2591-7.10126-2 Text en Copyright © 2009 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rondeau, Mark P.
Hepatitis and Cholangiohepatitis
title Hepatitis and Cholangiohepatitis
title_full Hepatitis and Cholangiohepatitis
title_fullStr Hepatitis and Cholangiohepatitis
title_full_unstemmed Hepatitis and Cholangiohepatitis
title_short Hepatitis and Cholangiohepatitis
title_sort hepatitis and cholangiohepatitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152088/
http://dx.doi.org/10.1016/B978-1-4160-2591-7.10126-2
work_keys_str_mv AT rondeaumarkp hepatitisandcholangiohepatitis